摘要
背景:淀粉样肽前体(APP)作为betaamyloid肽前体蛋白(β-淀粉样蛋白,Aβ)被认为在阿尔兹海默病(AD)的发病机制中扮演了中心的角色,同时他在AD发展进程中起着重要作用。通过在动物中敲入APP基于,我们设置了大量的AD神经转基因模型,为了研究AD发病机制同时筛选抗AD药物。然而,模型仍然存在一些局限性,所以需要一个经济适用同时有着人类基因同源的AD模型。 方法:我们通过敲入一个病变的人类APP基因(APPsw)在一个带有appb启动子能够促使表达APPsw基因的斑马鱼中,从而建立了一个新的AD转基因模型。 结果:荧光影像、免疫化学染色、RT-PCR和西式吸印杂交试验证明APPsw能在转基因斑马鱼大脑、心脏、研究和血管中成功表达。行为的观察阐明转基因斑马鱼拥有类似AD的症状。组织病理学的观察发现脑β-淀粉样变性和血管病(CAA),引起神经元的丢失和增加血运的空间。 结论:这些结果表明APPsw转基因斑马鱼很好的刺激了AD的发病特性同时能被用作一个经济的AD转基因模型。进一步说,新的模型表明APP能够在微血管中表达同时导致Aβ代和在沉积脑血管,进一步破坏脑血管结构,导致AD的发展和/或进展。
关键词: 阿尔兹海默病转基因模型,人类APP瑞典病变,斑马鱼appb启动子,Aβ沉积,微血管异常,神经丢失。
Current Alzheimer Research
Title:Generation of Alzheimer’s Disease Transgenic Zebrafish Expressing Human APP Mutation Under Control of Zebrafish appb Promotor
Volume: 14 Issue: 6
关键词: 阿尔兹海默病转基因模型,人类APP瑞典病变,斑马鱼appb启动子,Aβ沉积,微血管异常,神经丢失。
摘要: Background: Amyloid peptide precursor (APP) as the precursor protein of peptide betaamyloid (β-amyloid, Aβ), which is thought to play a central role in the pathogenesis of Alzheimer's disease (AD), also has an important effect on the development and progression of AD. Through knocking-in APP gene in animals, numerous transgenic AD models have been set up for the investigation of the mechanisms behind AD pathogenesis and the screening of anti-AD drugs. However, there are some limitations to these models and here is a need for such an AD model that is economic as well as has satisfactory genetic homology with human.
Methods: We generated a new AD transgenic model by knocking a mutant human APP gene (APPsw) in zebrafish with appb promoter of zebrafish to drive the expression of APPsw. Results: Fluorescent image and immunochemistry stain showed and RT-PCR and western blot assay confirmed that APPsw was successfully expressed in the brain, heart, eyes and vasculature of the transgenic zebrafish. Behavioral observation demonstrated that the transgenic zebrafish had AD-like symptoms. Histopathological observation found that there were cerebral β-amyloidosis and angiopathy (CAA), which induced neuron loss and enlarged pervascular space. Conclusion: These results suggest that APPsw transgenic zebrafish well simulate the pathological characters of AD and can be used as an economic AD transgenic model. Furthermore, the new model suggested that APP can express in microvasculatures and cause the Aβ generation and deposition in cerebral vessel which further destroys cerebral vascular structure resulting in the development and/or the progress of AD.Export Options
About this article
Cite this article as:
Generation of Alzheimer’s Disease Transgenic Zebrafish Expressing Human APP Mutation Under Control of Zebrafish appb Promotor, Current Alzheimer Research 2017; 14 (6) . https://dx.doi.org/10.2174/1567205013666161201202000
DOI https://dx.doi.org/10.2174/1567205013666161201202000 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
What Can Imaging Reveal about Obesity and the Brain?
Current Alzheimer Research Recent Progress and Related Patents on the Applications of Bone Marrow-Derived Stem/Progenitor Cells in Regenerative Medicine and Cancer Therapies
Recent Patents on Regenerative Medicine Chemokines as Potential Therapeutic Targets in Atherosclerosis
Current Drug Targets Advances in Clinical Study of Curcumin
Current Pharmaceutical Design Modifiable Risk Factors for Premature Atherosclerosis in Systemic Lupus Erythematosus
Vascular Disease Prevention (Discontinued) Disease Modifying Approaches for Alzheimers Pathology
Current Pharmaceutical Design Inhibition of Early Biochemical Defects in Prodromal Huntington’s disease by Simultaneous Activation of Nrf2 and Elevation of Multiple Micronutrients
Current Aging Science Novel Technologies for Dipeptide Drugs Design and their Implantation
Current Pharmaceutical Design Is Alzheimers Disease a Myth? When is Disease a Disease?
Current Alzheimer Research Regenerative Potential of Stem Cells Derived from Human Exfoliated Deciduous (SHED) Teeth during Engineering of Human Body Tissues
Current Stem Cell Research & Therapy Oxidative Stress Correlates (OSC) in Diabetes Mellitus Patients
Current Diabetes Reviews Polyphenols: Well Beyond The Antioxidant Capacity: Gallic Acid and Related Compounds as Neuroprotective Agents: You are What You Eat!
Current Pharmaceutical Biotechnology Selective Serotonin-norepinephrine Re-uptake Inhibition Limits Renovas-cular-hypertension Induced Cognitive Impairment, Endothelial Dysfunction, and Oxidative Stress Injury
Current Neurovascular Research Meet the Editorial Board:
Central Nervous System Agents in Medicinal Chemistry Natural Products and their (Semi-)Synthetic Forms in the Treatment of Migraine: History and Current Status
Current Medicinal Chemistry The Role of Berberine in the Multi-Target Treatment of Senile Dementia
Current Topics in Medicinal Chemistry Host Neuro- Immuno-Endocrine Responses In Periodontal Disease
Current Pharmaceutical Design Catastrophic Antiphospholipid Syndrome - 20 Years Later
Current Rheumatology Reviews Editorial: Advances in the Treatment of Neurodegenerative Diseases and Epilepsy
Current Pharmaceutical Design The Adult Patient with Eisenmenger Syndrome: A Medical Update after Dana Point Part II: Medical Treatment - Study Results
Current Cardiology Reviews